{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:02:40Z","timestamp":1790737360796,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","award":["G102329"],"award-info":[{"award-number":["G102329"]}],"id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20005"],"award-info":[{"award-number":["BRC-1215-20005"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["SUAG\/077 G101400"],"award-info":[{"award-number":["SUAG\/077 G101400"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bbi.2022.04.013","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T02:20:08Z","timestamp":1650248408000},"page":"154-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"special_numbering":"C","title":["Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections"],"prefix":"10.1016","volume":"103","author":[{"given":"Maxime","family":"Taquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Dercon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bbi.2022.04.013_b0005","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S2213-2600(21)00380-5","article-title":"COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2\u00b757 million people in Scotland (EAVE II): a prospective cohort study","volume":"9","author":"Agrawal","year":"2021","journal-title":"Lancet Respiratory Med."},{"key":"10.1016\/j.bbi.2022.04.013_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequalae of COVID-19","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbi.2022.04.013_b0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.bbi.2022.04.013_b0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav. Res."},{"key":"10.1016\/j.bbi.2022.04.013_b0025","doi-asserted-by":"crossref","first-page":"100065","DOI":"10.1016\/j.lana.2021.100065","article-title":"Vaccination reduces need for emergency care in breakthrough COVID-19 infections: a multicenter cohort study","volume":"4","author":"Bahl","year":"2021","journal-title":"The Lancet Regional Health - Americas"},{"key":"10.1016\/j.bbi.2022.04.013_b0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijid.2021.08.008","article-title":"Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination","volume":"110","author":"Butt","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbi.2022.04.013_b0035","article-title":"Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study","volume":"374","author":"Cabezas","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.bbi.2022.04.013_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-publhealth-032315-021353","article-title":"Using electronic health records for population health research: a review of methods and applications","volume":"37","author":"Casey","year":"2016","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.bbi.2022.04.013_b0045","article-title":"Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study","volume":"373","author":"Daugherty","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.bbi.2022.04.013_b0050","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1473-3099(20)30371-6","article-title":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study","volume":"20","author":"de Lusignan","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbi.2022.04.013_b0055","doi-asserted-by":"crossref","first-page":"103574","DOI":"10.1016\/j.ebiom.2021.103574","article-title":"The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: a nation-wide retrospective longitudinal multiple cohort analysis using individualised data","volume":"72","author":"Glatman-Freedman","year":"2021","journal-title":"EBioMedicine"},{"issue":"10287","key":"10.1016\/j.bbi.2022.04.013_b0060","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2022.04.013_b0065","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.bbi.2022.04.013_b0070","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S1473-3099(21)00330-3","article-title":"Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study","volume":"21","author":"Hyams","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.bbi.2022.04.013_b0075","doi-asserted-by":"crossref","first-page":"e0246970","DOI":"10.1371\/journal.pone.0246970","article-title":"Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US","volume":"16","author":"Latkin","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2022.04.013_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2016.12.001","article-title":"Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations","volume":"82","author":"Manja","year":"2017","journal-title":"J. Clin. Epidemiol."},{"issue":"25","key":"10.1016\/j.bbi.2022.04.013_b0085","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.25.2100507","article-title":"Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021","volume":"26","author":"Mateo-Urdiales","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.bbi.2022.04.013_b0090","article-title":"Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State","author":"McEwen","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2022.04.013_b0095","unstructured":"Nixon, D.F., Ndhlovu, L.C., 2021. Vaccine breakthrough infections with SARS-CoV-2 variants. N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2022.04.013_b0100","article-title":"Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis","volume":"373","author":"Nyberg","year":"2021","journal-title":"BMJ"},{"issue":"27","key":"10.1016\/j.bbi.2022.04.013_b0105","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2022.04.013_b0110","unstructured":"Roest, S., Hoek, R.A.S., Manintveld, O.C., 2021. BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting. N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bbi.2022.04.013_b0115","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.bbi.2022.04.013_b0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.bbi.2022.04.013_b0125","doi-asserted-by":"crossref","first-page":"e1003773","DOI":"10.1371\/journal.pmed.1003773","article-title":"Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19","volume":"18","author":"Taquet","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbi.2022.04.013_b0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2022.04.013_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bbi.2022.04.013_b0140","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMc2102179","article-title":"Serum neutralizing activity elicited by mRNA-1273 vaccine","volume":"384","author":"Wu","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:17:37Z","timestamp":1760170657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159122001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"alternative-id":["S0889159122001118"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2022.04.013","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.26.21265508","asserted-by":"object"}]},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2022.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}